Investment Summary

Quadria Capital Invests In Lablink

On January 23, 2018, private equity firm Quadria Capital invested in life science company Lablink

Investment Highlights
  • This is Quadria Capital’s 2nd transaction in the Life Science sector.
  • This is Quadria Capital’s 1st transaction in Malaysia.

Investment Summary

Date 2018-01-23
Target Lablink
Sector Life Science
Investor(s) Quadria Capital
Deal Type Stake Purchase

Target

Lablink

Kuala Lumpur, Malaysia
Lablink is a hospital laboratories, offering high quality diagnostic services through its central lab in and managing over 25 hospital laboratories across Malaysia. The company’s comprehensive services include haematology, chemical pathology, immunology & serology, histology, biosafety & mycobacteriology, medical microbiology, cytology, molecular diagnostics, and health screening. Lablink was founded in 1989 and is based in Kuala Lumpur, Malaysia.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Quadria Capital

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2012
PE ASSETS 1.5B USD
Size Large
Type Sector Focused
DESCRIPTION

Quadria Capital is a private equity firm focused on investing in the healthcare sector throughout Southeast Asia and India. The Firm looks to partner with promising regional healthcare companies and help them grow into leaders. Specific areas of interest include life science, healthcare delivery, medical technology, and other healthcare services. Quadria Capital was formed in 2012 and is headquartered in Singapore.


DEAL STATS #
Overall 8 of 13
Sector (Life Science) 2 of 4
Type (Stake Purchase) 3 of 4
Country (Malaysia) 1 of 1
Year (2018) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-11 Royal Healthcare

Singapore , Singapore

Royal Healthcare is a multi-disciplinary specialist centre with highly experienced and talented medical specialists using the latest in medical technology to deliver optimal healthcare outcomes to our patients. Royal Healthcare was founded in 2022 and is based in Singapore.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-08 Akums

Delhi, India

Akums is a manufacturing pharmaceutical company of India. The organization deals in the manufacturing and export of formulations in a wide spectrum of dosage forms & therapeutic segments. Akums was founded in 2004 and is based in Delhi, India.

Buy -